Research
Hormonal
Carbohydrate restriction leads to appetite reduction, weight loss, and improvements in glycemic and insulin control.
Practitioners may consider carbohydrate restriction as a strategy for managing obesity and T2DM.
StrongSupportsmedium confidence
Clinical studies have shown that carbohydrate restriction leads to appetite reduction, weight loss, and improvements in glycemic and insulin control.
Why this rating
Based on clinical studies mentioned in the abstract.
Source
Low-Carbohydrate, Ketogenic Diets for the Treatment of Type 2 Diabetes and Obesity
Eric C. Westman et al. · 2022
DOI 10.1093/med/9780197501207.003.0039
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →